Skip to main content
European Commission logo print header

Generation of bioengineered pancreatic islet microorgans for insulin replacement therapy in diabetes mellitus

Objective

Diabetes is a major health problem in Europe. Limited availability of donor tissue restricts conventional transplant treatments. Therefore, we propose to bioengineer pancreatic islet microorgans (called pseudoislets) using glucose-responsive insulin-producing cells of differentiated stem cell origin. These microorgans should be suitable substitutes to restore the function of the destroyed pancreatic islets in a diabetic individual. The combination of the bioengineering of insulin-secreting surrogate cells with techniques for generation of a pancreatic islet microorgan represents a highly innovative experimental approach. This Cell Factory concept for an innovative insulin replacement therapy, applied to cells of human origin, can offer, due to the unlimited supply, a cure to many diabetic patients. The long-standing expertise and experience of the partners in this proposal bring together the capabilities to achieve this highly desirable goal.

Call for proposal

Data not available

Coordinator

HANNOVER MEDICAL SCHOOL
EU contribution
No data
Address
CARL-NEUBERG-STRASSE 1
30625 HANNOVER
Germany

See on map

Total cost
No data

Participants (6)